Skip to main content
Journal of Korean Medical Science logoLink to Journal of Korean Medical Science
. 2002 Apr;17(2):254–259. doi: 10.3346/jkms.2002.17.2.254

Outcome of postoperative intratumoral bleomycin injection for cystic craniopharyngioma.

Dong Hyuk Park 1, Jung Yul Park 1, Joo Han Kim 1, Yong Gu Chung 1, Hoon Kap Lee 1, Ki Chan Lee 1, Jung Keun Suh 1
PMCID: PMC3054855  PMID: 11961313

Abstract

Total excision is a treatment of choice in preventing the relapse of craniopharyngioma, but for tumors involving an extensive area, it is often associated with an increased risk of complications. We have performed a partial or subtotal tumor removal followed by repeated injection of bleomycin into the remaining tumor through a subcutaneous reservoir as postoperative adjuvant therapy. A retrospective review of clinical, radiological, and surgical data was performed for 10 patients (5 males and 5 females; age, 3-65 yr; follow-up duration, 12-79 months) with cystic craniopharyngiomas. The measurements of lactate dehydrogenase (LDH) level at each aspiration were performed. The shrinkage and/or stabilization of tumor was initially noted in all cases. The recurrence of tumor was seen in 4 cases (40%). The decreased or increased level of LDH was interpreted as tumor shrinkage or recurrence, respectively. The transient toxic reactions were observed in 3 patients (30%). Our study demonstrates that postoperative bleo-mycin injection for cystic craniopharyngioma, although does not appear to eradicate the tumor, decreases and stabilizes the tumor size, when used as an adjuvant therapy in young patients.

Full Text

The Full Text of this article is available as a PDF (197.8 KB).


Articles from Journal of Korean Medical Science are provided here courtesy of Korean Academy of Medical Sciences

RESOURCES